A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L)
Kenichi Nakamura, Masahiro Tsuboi(National Cancer Center Hospital East), Hisashi Saji(St. Marianna University School of Medicine), Tatsuhiro Shibata(The University of Tokyo), Hisao Asamura(Keio University), Hirohito Tada(Osaka City General Hospital), Shinichiro Nakamura(Japan Clinical Cancer Research Organization), M. Okada(Hiroshima University Hospital), R. Nakajima(Osaka City General Hospital)
Cited by 527
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k